Cargando…

Interstitial lung disease in rheumatoid arthritis: incidence, prevalence and related drug prescriptions between 2007 and 2020

OBJECTIVE: To investigate prevalence, incidence and medication of interstitial lung disease (ILD) among German individuals with rheumatoid arthritis (RA). METHODS: Nationwide BARMER claims data from 2007 to 2020 were used. RA-ILD was identified by diagnosis codes, prescription of disease-modifying a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Albrecht, Katinka, Strangfeld, Anja, Marschall, Ursula, Callhoff, Johanna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2023
Materias:	Epidemiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9872506/ https://www.ncbi.nlm.nih.gov/pubmed/36669830 http://dx.doi.org/10.1136/rmdopen-2022-002777

Ejemplares similares

Comorbidity and healthcare utilisation in persons with incident systemic lupus erythematosus followed for 3 years after diagnosis: analysis of a claims data cohort
por: Albrecht, Katinka, et al.
Publicado: (2021)

High burden of polypharmacy and comorbidity in persons with psoriatic arthritis: an analysis of claims data, stratified by age and sex
por: Albrecht, Katinka, et al.
Publicado: (2023)

Steigt die Prävalenz der rheumatoiden Arthritis wirklich an?
por: Albrecht, Katinka, et al.
Publicado: (2022)

Body mass index distribution in rheumatoid arthritis: a collaborative analysis from three large German rheumatoid arthritis databases
por: Albrecht, Katinka, et al.
Publicado: (2016)

Osteoporosis in patients with rheumatoid arthritis: trends in the German National Database 2007–2017
por: Lindner, Lisa, et al.
Publicado: (2020)

Is the Rheumatoid Arthritis Impact of Disease (RAID) score a meaningful instrument for other inflammatory rheumatic diseases? A cross-sectional analysis of data from the German National Database
por: Thiele, Katja, et al.
Publicado: (2022)

Verordnungshäufigkeit von physikalischer Therapie bei entzündlich rheumatischen Erkrankungen
por: Albrecht, Katinka, et al.
Publicado: (2022)

33 Jahre DRFZ: Epidemiologie und Versorgungsforschung
por: Strangfeld, Anja, et al.
Publicado: (2022)

Maternal and infant outcomes in pregnancies of women with axial spondyloarthritis compared with matched controls: results from nationwide health insurance data
por: Redeker, Imke, et al.
Publicado: (2022)

Systematisches Review zur Schätzung der Prävalenz entzündlich rheumatischer Erkrankungen in Deutschland
por: Albrecht, Katinka, et al.
Publicado: (2023)

Incidence of seropositive rheumatoid arthritis in population-based studies in Northern Savo, Finland, during 1980–2020
por: Elfving, Pia, et al.
Publicado: (2023)

Factors associated with treatment satisfaction in patients with rheumatoid arthritis: data from the biological register RABBIT
por: Schäfer, Martin, et al.
Publicado: (2020)

Prescription of analgesics in patients with rheumatic diseases in Germany: A claims data analysis
por: Albrecht, K., et al.
Publicado: (2021)

Mortality in rheumatoid arthritis: the impact of disease activity, treatment with glucocorticoids, TNFα inhibitors and rituximab
por: Listing, Joachim, et al.
Publicado: (2015)

Depression is a stronger predictor of the risk to consider work disability in early arthritis than disease activity or response to therapy
por: Callhoff, Johanna, et al.
Publicado: (2015)

Geschlechtsspezifische Unterschiede in Diagnostik und Therapie entzündlich-rheumatischer Erkrankungen
por: Albrecht, Katinka, et al.
Publicado: (2023)

Leukaemia incidence in the Techa River Cohort: 1953–2007
por: Krestinina, L Y, et al.
Publicado: (2013)

Risk of major adverse cardiovascular events in patients with rheumatoid arthritis treated with conventional synthetic, biologic and targeted synthetic disease-modifying antirheumatic drugs: observational data from the German RABBIT register
por: Meissner, Yvette, et al.
Publicado: (2023)

Risk of herpes zoster (shingles) in patients with rheumatoid arthritis under biologic, targeted synthetic and conventional synthetic DMARD treatment: data from the German RABBIT register
por: Redeker, Imke, et al.
Publicado: (2022)

Impact of treatment with biologic DMARDs on the risk of sepsis or mortality after serious infection in patients with rheumatoid arthritis
por: Richter, A, et al.
Publicado: (2016)

Serious adverse events and the risk of stroke in patients with rheumatoid arthritis: results from the German RABBIT cohort
por: Meissner, Y, et al.
Publicado: (2017)

Incidence trends of vestibular schwannomas in Denmark, Finland, Norway and Sweden in 1987–2007
por: Larjavaara, S, et al.
Publicado: (2011)

HIV Incidence, Recent HIV Infection, and Associated Factors, Kenya, 2007–2018
por: Young, Peter Wesley, et al.
Publicado: (2023)

Rheumatoid interstitial lung disease in Canterbury New Zealand: prevalence, risk factors and long-term outcomes—protocol for a population-based retrospective study
por: Farquhar, Hamish, et al.
Publicado: (2022)

Risk for lower intestinal perforations in patients with rheumatoid arthritis treated with tocilizumab in comparison to treatment with other biologic or conventional synthetic DMARDs
por: Strangfeld, A, et al.
Publicado: (2017)

Incidence of facial nerve palsies stratified by DMARD treatment in patients with rheumatoid arthritis: data from the RABBIT register
por: Meissner, Yvette, et al.
Publicado: (2020)

A patient-reported questionnaire developed in a German early arthritis cohort to assess periodontitis in patients with rheumatoid arthritis
por: Callhoff, Johanna, et al.
Publicado: (2019)

Prevalence of hypertension at high altitude: cross-sectional survey in Ladakh, Northern India 2007–2011
por: Norboo, Tsering, et al.
Publicado: (2015)

Two-dose COVID-19 vaccination and possible arthritis flare among patients with rheumatoid arthritis in Hong Kong
por: Li, Xue, et al.
Publicado: (2022)

Quality of life, sleep and rheumatoid arthritis (QUASAR): a protocol for a prospective UK mHealth study to investigate the relationship between sleep and quality of life in adults with rheumatoid arthritis
por: Druce, Katie L, et al.
Publicado: (2018)

Spectrum of lymphomas across different drug treatment groups in rheumatoid arthritis: a European registries collaborative project
por: Mercer, Louise K, et al.
Publicado: (2017)

Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: results from a collaborative project of 11 European biologic registers
por: Mercer, Louise K, et al.
Publicado: (2017)

The future burden of cancer in England: incidence and numbers of new patients in 2020
por: Møller, H, et al.
Publicado: (2007)

The prevalence and impact of comorbidities on patients with axial spondyloarthritis: results from a nationwide population-based study
por: Redeker, Imke, et al.
Publicado: (2020)

Prevalence of rheumatoid arthritis and diagnostic validity of a prediction score, in patients visiting orthropedic clinics in the Madinah region of Saudi Arabia: a retrospective cross-sectional study
por: Mir, Shabir Ahmad, et al.
Publicado: (2022)

Factors Associated with Survey Non-Response in a Cross-Sectional Survey of Persons with an Axial Spondyloarthritis or Osteoarthritis Claims Diagnosis
por: Callhoff, Johanna, et al.
Publicado: (2020)

Prescription drugs with potential for misuse: protocol for a multi-indicator analysis of supply, detection and the associated health burden in Ireland between 2010 and 2020
por: Cousins, Gráinne, et al.
Publicado: (2023)

Risk of incident or recurrent malignancies among patients with rheumatoid arthritis exposed to biologic therapy in the German biologics register RABBIT
por: Strangfeld, Anja, et al.
Publicado: (2010)

Incidence of interstitial pneumonitis among breast cancer patients: a 10-year Danish population-based cohort study
por: Christensen, S, et al.
Publicado: (2008)

Validation of an algorithm to identify incident interstitial lung disease in patients with rheumatoid arthritis
por: Meehan, M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8c5b1abu8vn6efn9dq4qi078pl